Drug interactions
Cisatracurium + Indacaterol-glycopyrronium
Severity: Minor
Cisatracurium and Indacaterol-glycopyrronium: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Cisatracurium is a neuromuscular blocker acting at nicotinic receptors, whereas glycopyrronium acts at muscarinic receptors, so there is no meaningful shared effect. Systemic exposure to inhaled glycopyrronium is low, and no clinically significant interaction is established.
What this interaction means in plain words
Cisatracurium and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Cisatracurium belongs to Musculoskeletal; Indacaterol-glycopyrronium belongs to Respiratory.
Why it happens
No established mechanism; the drugs act at different receptor types.
What to do
No specific action is needed beyond routine neuromuscular monitoring during anesthesia.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Cisatracurium and Indacaterol-glycopyrronium, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Indacaterol-glycopyrronium
Other interactions of Cisatracurium
Frequently asked questions
Can I take Cisatracurium with Indacaterol-glycopyrronium?
MediHelp rates the interaction as minor. Cisatracurium and Indacaterol-glycopyrronium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Cisatracurium is a neuromuscular blocker acting at nicotinic receptors, whereas glycopyrronium acts at muscarinic receptors, so there is no meaningful shared effect. Systemic exposure to inhaled glycopyrronium is low, and no clinically significant interaction is established.
How serious is the interaction between Cisatracurium and Indacaterol-glycopyrronium?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No specific action is needed beyond routine neuromuscular monitoring during anesthesia.
What other medicines interact with Indacaterol-glycopyrronium?
MediHelp also lists interactions of Indacaterol-glycopyrronium with, for example, Amisulpride, Arformoterol, Arsenic trioxide. The full list is on the Indacaterol-glycopyrronium page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
